What might the future of prescription drugs look like under Trump?

The latest stories trending on MedCity News.

Editor's Pick

Top Story What Might the Future of Prescription Drugs Look Like Under Trump? Experts agree that the incoming Trump administration will likely shake things up in the prescription drug world — most notably when it comes to research and development, drug pricing and PBM reform. Sponsored Biotech Showcase™: 17 years of innovation and opportunity Presented by Biotech Showcase™ & EBD Group Join Biotech Showcase, Jan 13-15, 2025—the premier conference for private, small-cap, seed, and techbio companies. Connect with key investors during the healthcare sector's most pivotal week. Learn more! Take the Spotlight at INVEST 2025: Pitch Your Startup Let your pitch be the catalyst that propels your startup from a disruptive idea into a transformative force. Apply now to participate in the Pitch Perfect Contest at INVEST 2025 in Chicago April 29-30. Each Pitch Track winner will receive a $20,000 advertising credit to be used on MedCityNews.com. Submit Your Pitch Application Today

Featured News

Where Can Self-Insured Employers Look to Find Healthcare Savings? Are you a self-insured employer looking for ways to reduce healthcare spend? Join us for a webinar on December 11 in which HR executives will share their insights. Where Medicare Advantage Goes From Here Now is the time for health plans to step up and embrace the tools and strategies that will not only meet regulatory demands, but also drive innovation in care delivery.  Fort Health Secures $5.5M to Expand Access to Integrated Pediatric Mental Health Care Fort Health's $5.5 million in funding was led by Twelve Below and Vanterra and included participation from Redesign Health, Blue Venture Fund and True Wealth Ventures. Neurogene Gene Therapy Shows Signs of Efficacy in Small Study, But an Adverse Event Spooks Investors Neurogene's Rett syndrome gene therapy has preliminary data supporting safety and efficacy of the one-time treatment. But a late-breaking report of a serious complication in a patient who received the high dose sent shares of the biotech downward. Unlocking the Future of Radioligand Therapy: From Discovery to Delivering at Scale As radiopharmaceuticals enter a new phase, industry leaders must rethink external services and internal capabilities to master the complexities of delivering advanced therapies.

Resources

SPONSORED EMR Software Pricing Guide How do you know if you're spending too much or too little on EMR software? This guide from Software Advice breaks down upfront, subscription and hidden costs, plus answers other questions you've been wondering about. Download Free Guide Now

MedCity News • PO Box 901 • New York, NY unsubscribe